Literature DB >> 7891679

Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene.

P Ducy1, G Karsenty.   

Abstract

Osteoblasts are cells of mesodermal origin that play a pivotal role during bone growth and mineralization. The mechanisms governing osteoblast-specific gene expression are still unknown. To understand these mechanisms, we analyzed the cis-acting elements of mouse osteocalcin gene 2 (mOG2), the best-characterized osteoblast-specific gene, by DNA transfection experiments in osteoblastic and nonosteoblastic cell lines and by DNA-binding assays. 5' deletion analysis of an mOG2 promoter-luciferase chimeric gene showed that a region located between -147 and -34 contained most if not all of the regulatory elements required for osteoblast-specific expression. Three different binding sites, called A, B, and C, for factors present in nuclear extracts of osteoblasts were identified in this short promoter by DNase I footprint assays. In gel retardation assays, the A element, located between bp -64 and -47, bound a factor present only in nuclear extracts of osteoblastic cell lines and nonmineralizing primary osteoblasts. The B element, located between bp -110 and -83, bound a ubiquitously expressed factor. The C element, located between bp -146 and -132, bound a factor present only in nuclear extracts of osteoblastic cell lines and nonmineralizing and mineralizing primary osteoblasts. When cloned upstream of a minimum osteocalcin promoter or a heterologous promoter, multimers of the A element strongly increased the activities of these promoters in osteoblastic cell lines at two different stages of differentiation but in no other cell line; we named this element osteocalcin-specific element 1 (OSE1). Multimers of the C element increased the activities of these promoters predominantly in a differentiated osteoblastic cell line; we named this element OSE2. This study demonstrates that two distinct cis-acting elements are responsible for osteoblast expression of mOG2 and provides for the first time a functional characterization of osteoblast-specific cis-acting elements. We speculate that these two elements may be important at several stages of osteoblast differentiation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7891679      PMCID: PMC230411          DOI: 10.1128/MCB.15.4.1858

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  42 in total

Review 1.  MyoD family: a paradigm for development?

Authors:  E N Olson
Journal:  Genes Dev       Date:  1990-09       Impact factor: 11.361

2.  Inefficient homooligomerization contributes to the dependence of myogenin on E2A products for efficient DNA binding.

Authors:  T Chakraborty; T J Brennan; L Li; D Edmondson; E N Olson
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

3.  Compilation of vertebrate-encoded transcription factors.

Authors:  S Faisst; S Meyer
Journal:  Nucleic Acids Res       Date:  1992-01-11       Impact factor: 16.971

4.  Establishment of an osteogenic cell line derived from adult mouse bone marrow stroma by use of a recombinant retrovirus.

Authors:  E Mathieu; G Schoeters; F vander Plaetse; J Merregaert
Journal:  Calcif Tissue Int       Date:  1992-04       Impact factor: 4.333

Review 5.  The family of collagen genes.

Authors:  E Vuorio; B de Crombrugghe
Journal:  Annu Rev Biochem       Date:  1990       Impact factor: 23.643

6.  1,25-dihydroxyvitamin D-responsive element and glucocorticoid repression in the osteocalcin gene.

Authors:  N A Morrison; J Shine; J C Fragonas; V Verkest; M L McMenemy; J A Eisman
Journal:  Science       Date:  1989-12-01       Impact factor: 47.728

7.  A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins.

Authors:  C Murre; P S McCaw; D Baltimore
Journal:  Cell       Date:  1989-03-10       Impact factor: 41.582

8.  Nucleotides flanking a conserved TAAT core dictate the DNA binding specificity of three murine homeodomain proteins.

Authors:  K M Catron; N Iler; C Abate
Journal:  Mol Cell Biol       Date:  1993-04       Impact factor: 4.272

9.  Identification of a DNA sequence involved in osteoblast-specific gene expression via interaction with helix-loop-helix (HLH)-type transcription factors.

Authors:  M Tamura; M Noda
Journal:  J Cell Biol       Date:  1994-08       Impact factor: 10.539

10.  Differential utilization of regulatory domains within the alpha 1(I) collagen promoter in osseous and fibroblastic cells.

Authors:  D Pavlin; A C Lichtler; A Bedalov; B E Kream; J R Harrison; H F Thomas; G A Gronowicz; S H Clark; C O Woody; D W Rowe
Journal:  J Cell Biol       Date:  1992-01       Impact factor: 10.539

View more
  195 in total

1.  Lyso-phosphatidylcholine induces osteogenic gene expression and phenotype in vascular smooth muscle cells.

Authors:  Kasey C Vickers; Fernando Castro-Chavez; Joel D Morrisett
Journal:  Atherosclerosis       Date:  2010-04-14       Impact factor: 5.162

2.  Increased production of IL-7 uncouples bone formation from bone resorption during estrogen deficiency.

Authors:  M Neale Weitzmann; Cristiana Roggia; Gianluca Toraldo; Louise Weitzmann; Roberto Pacifici
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

3.  A WW domain-containing yes-associated protein (YAP) is a novel transcriptional co-activator.

Authors:  R Yagi; L F Chen; K Shigesada; Y Murakami; Y Ito
Journal:  EMBO J       Date:  1999-05-04       Impact factor: 11.598

4.  Interactions between extracellular signal-regulated kinase 1/2 and p38 MAP kinase pathways in the control of RUNX2 phosphorylation and transcriptional activity.

Authors:  Chunxi Ge; Qian Yang; Guisheng Zhao; Hong Yu; Keith L Kirkwood; Renny T Franceschi
Journal:  J Bone Miner Res       Date:  2012-03       Impact factor: 6.741

5.  p53 and MDM2 are involved in the regulation of osteocalcin gene expression.

Authors:  Hankui Chen; Kevin Kolman; Natalie Lanciloti; Michael Nerney; Emily Hays; Chet Robson; Nalini Chandar
Journal:  Exp Cell Res       Date:  2012-03-03       Impact factor: 3.905

6.  ChIP Display: novel method for identification of genomic targets of transcription factors.

Authors:  Artem Barski; Baruch Frenkel
Journal:  Nucleic Acids Res       Date:  2004-07-13       Impact factor: 16.971

7.  Serine phosphorylation of RUNX2 with novel potential functions as negative regulatory mechanisms.

Authors:  Hee-Jun Wee; Gang Huang; Katsuya Shigesada; Yoshiaki Ito
Journal:  EMBO Rep       Date:  2002-09-13       Impact factor: 8.807

8.  [Immunohistochemical study on collagen I content in the gingiva in cleidocranial dysplasia].

Authors:  Tobias Ach; Uwe Baumert; Christian Morsczeck; Regine Dahse; Torsten Eugen Reichert; Oliver Driemel
Journal:  Mund Kiefer Gesichtschir       Date:  2007-12

9.  The regulation of runt-related transcription factor 2 by fibroblast growth factor-2 and connexin43 requires the inositol polyphosphate/protein kinase Cδ cascade.

Authors:  Corinne Niger; Maria A Luciotti; Atum M Buo; Carla Hebert; Vy Ma; Joseph P Stains
Journal:  J Bone Miner Res       Date:  2013-06       Impact factor: 6.741

10.  Transgenic mice expressing a ligand-inducible cre recombinase in osteoblasts and odontoblasts: a new tool to examine physiology and disease of postnatal bone and tooth.

Authors:  Jung-Eun Kim; Kazuhisa Nakashima; Benoit de Crombrugghe
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.